Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MA03 - Clinomics and Genomics
- 10:30 - 12:00
- 9/08/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Heather A Wakelee, Wilfried Ernst Erich Eberhardt
-
+
MA03.09 - Dramatic Responses to Immune Checkpoint Inhibitors in MET Exon 14 Skipping Mutation (METex14mut) Non Small Cell Lung Cancers
11:30 - 11:35 | Presenter: Marie Mayenga | Author(s): Isabelle Monnet, Marie-Ange Massiani, Jean-Baptiste Assié, Laure Tabeze, Sylvie Friard, Severine Fraboulet, Anne-Cécile Metivier, Christos Chouaid, Leila Zemoura, Elisabeth Longchampt, Samia Melaabi, Louis-Jean Couderc, Helene Doubre
- Abstract
Loading...
-
+
MA07 - Clinical Questions and Potential Blood Markers for Immunotherapy
- 13:30 - 15:00
- 9/08/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:David R Spigel, Roberto Ferrara
-
+
MA07.06 - Immunotherapy Re-Challenge After Nivolumab Treatment in Advanced Non-Small Cell Lung Cancer in French Real-World Setting
14:05 - 14:10 | Presenter: Matteo Giaj Levra | Author(s): François-Emery Cotté, Romain Corre, Christophe Calvet, Baptiste Jouaneton, Ronan Jolivel, Anne-Françoise Gaudin, Valentine Grumberg, Jean-Baptiste Assié, Christos Chouaid
- Abstract
Loading...
-
+
P1.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
P1.16-46 - Genetic Testing Patterns, Treatment Characteristics, and Overall Survival in ALK-Positive Metastatic NSCLC Patients Treated with Ceritinib
09:45 - 09:45 | Presenter: Julien Mazieres | Author(s): Myung-Ju Ahn, Christos Chouaid, Anna Kron, Juergen Wolf, Ravi K. Goyal, Keith L Davis, Maurice Perrinjaquet, Timothy Pham, Stefanie Knoll
- Abstract
Loading...
-
+
MA14 - The Adequate MTarget Is Still the Issue
- 15:45 - 17:15
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Diego Signorelli, Juergen Wolf
-
+
MA14.06 - Nintedanib-Docetaxel in 2nd Line Treatment in No Squamous Non-Small Cell Lung Cancer Patients, Refractory to First Line Treatment (GFPC02-15)
16:20 - 16:25 | Presenter: Alain Vergnenegre | Author(s): Jean Bernard Auliac, Isabelle Monnet, acya Bizieux, Laurent Greillier, Lionel Falchero, Gilles Robinet, Regien Lamy, Pierre-Alexandre Hauss, Florian Guisier, Hervé Lena, Christos Chouaid
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-09 - VinMetAtezo: Phase II Trial of Metronomic Oral Vinorelbine with Atezolizumab for Recurrent Stage IV NSCLC (GFPC*04-08)
10:15 - 10:15 | Presenter: Alain Vergnenegre | Author(s): Gilles Robinet, Christos Chouaid, acya Bizieux, Isabelle Monnet, Charles Ricordel
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-03 - Nivolumab Outcomes in Octogenarian Patients with Advanced Non-Small Cell Lung Cancer in French Real-World Setting
10:15 - 10:15 | Presenter: Christos Chouaid | Author(s): Jean-Baptiste Assié, François-Emery Cotté, Matteo Giaj Levra, Christophe Calvet, Ronan Jolivel, Baptiste Jouaneton, Anne-Françoise Gaudin, Valentine Grumberg, Romain Corre
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P2.14-65 - Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E–Mutant NSCLC in Real World Setting
10:15 - 10:15 | Presenter: Jean Bernard Auliac | Author(s): Sophie Bayle, Pascal Do, Gwenaëlle Legarff, Florian Guisier, Magali Roa, Lionel Falchero, Eric Huchon, Gilles Quere, Gaelle Jeannin, Helene Doubre, Mariette Baud, Joelle Hobeika, Christos Chouaid
- Abstract
Loading...
-
+
OA15 - Targeted Agents and Immunotherapy for Small Cell Lung Cancer
- 14:30 - 16:00
- 9/10/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Raffaele Califano, Charles M Rudin
-
+
OA15.02 - Carboplatin-Etoposide Versus Topotecan as Second-Line Treatment for Sensitive Relapsed Small-Cell Lung Cancer: Phase 3 Trial
14:40 - 14:50 | Presenter: Isabelle Monnet | Author(s): Nathalie Baize, Laurent Greillier, Margaux Geier, Hervé Lena, Henri Janicot, Alain Vergnenegre, Jacqhy Crequit, Regien Lamy, Jean Bernard Auliac, Jacques Le Treut, Hervé Le Caer, Radj Gervais, Eric Dansin, Anne Madroszyk, Patrick Renault, Gwenaëlle Legarff, Roland Schott, Patrick Saulnier, Christos Chouaid
- Abstract
Loading...